Behind the Study: Symmetry and Symmetry Breaking in Cancer
Dr. Kenneth J. Pienta and Dr. J. James Frost describe their 2017 study published by... read more
May 3, 2021
Category: Oncotarget
New Analogs of Mibefradil Created as Radiosensitizers for Glioblastoma
Researchers from Yale University conducted a study to create mibefradil analogs as superior radiosensitizers in... read more
April 28, 2021
Table of Contents: Oncotarget’s Volume 12, Issue #9
Read short summaries of the latest research published by Oncotarget.Origin: Connecticut, ... read more
April 27, 2021
Behind the Study: Prognostic Role of mir-24-3p in Breast Cancer
Researchers from NYU discuss their 2018 study published in Oncotarget, entitled, "Prognostic role of elevated... read more
April 26, 2021
Trending with Impact: Acute Myeloid Leukemia and Midostaurin Response
Researchers examined midostaurin resistance and sensitivity in a cohort of patients with acute myeloid leukemia.... read more
April 22, 2021
Behind the Study: miRNA-185 Emerges as Regulator of KRAS
Harvard Medical School Professor Frank Slack discusses his 2016 study published in Oncotarget, entitled, “Cis-acting... read more
April 18, 2021
A New Potential Network of Biomarkers Useful Across Sarcomas
Researchers examined five potential prognostic and therapeutic biomarkers across 18 different histologic subtypes of sarcoma... read more
April 14, 2021
Table of Contents: Oncotarget’s Volume 12, Issue #8
Read short summaries of the latest research published by Oncotarget.Origin: Iowa, Alabama, Minnesota,... read more
April 13, 2021
Behind the Study: Wnt Signaling Perturbs Spermatogenesis
Dr. Pradeep Tanwar discusses his study published in Oncotarget in 2016, entitled, "Germ cell-specific sustained... read more
April 12, 2021
Trending with Impact: The Vitamin D Binding Protein in Thyroid Cancer
Researchers compared vitamin D binding protein expression in papillary thyroid cancer tissues among Filipino American... read more
April 8, 2021